RUBICON Company Profile
✉ Email this page to a colleague
What is the competitive landscape for RUBICON, and what generic and branded alternatives to RUBICON drugs are available?
RUBICON has sixty-one approved drugs.
There is one tentative approval on RUBICON drugs.
Drugs and US Patents for RUBICON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rubicon | LORATADINE | loratadine | TABLET, ORALLY DISINTEGRATING;ORAL | 214280-001 | Sep 10, 2020 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Rubicon | ISOSORBIDE DINITRATE | isosorbide dinitrate | TABLET;ORAL | 215723-003 | Jul 8, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Rubicon | AMITRIPTYLINE HYDROCHLORIDE | amitriptyline hydrochloride | TABLET;ORAL | 215376-001 | May 1, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Rubicon | NITROGLYCERIN | nitroglycerin | TABLET;SUBLINGUAL | 209779-001 | May 3, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Rubicon | MIDODRINE HYDROCHLORIDE | midodrine hydrochloride | TABLET;ORAL | 212543-001 | Aug 19, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Rubicon | SILDENAFIL CITRATE | sildenafil citrate | TABLET;ORAL | 204882-002 | Jun 11, 2018 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.